Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Expects Favorable Labeling For Oncologic Sutent

Jan 05 2006

• By Andrew Kasper

Related Content

Pfizer's Sutent Gets Fast-Track Status From FDA

Aug 10 2005

Bayer/Onyx’ Nexavar Approved For Kidney Cancer

Dec 20 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window